Researcher seeks answers for epigenetic abnormalities leading to cancer diagnoses
Chemical Biology and Medicinal Chemistry Brittany Jennings October 30, 2019 Lindsey Ingerman James, Ph.D. Lindsey Ingerman James, Ph.D., with the UNC Eshelman School of Pharmacy is interested in epigenetic abnormalities that lead to cancer. For example, misregulation of the NSD2 … Read more
Newly promoted associate professor Hathaway published in Nature Biotechnology
Veronica Correa November 27, 2019 Nathaniel Hathaway, Ph.D., a researcher at the UNC Eshelman School of Pharmacy’s Division of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery and the Lineberger Comprehensive Cancer Center, was published … Read more
Pinnacle Hill Announces First Project Agreement
Chemical Biology and Medicinal Chemistry Brittany Jennings December 18, 2019 Alliance Between UNC-Chapel Hill and Deerfield intends to advance select Carolina innovations toward a possible new treatment against multiple myeloma Lindsey Ingerman James, Ph.D. Pinnacle Hill, the research and development … Read more